"Bharat Biotech reported promising data on the nasal #Covid #vaccine this week. The #NasalVaccine against Covid was safe, well tolerated & elicited superior antibody levels & mucosal immune responses compared with 2 doses of the intramuscular #Covaxin vaccine. Hopefully this nasal vaccine will be approved in the United States soon as it helps block the Covid virus from entering the body." 3/n

https://drruth.substack.com/p/covid-news-2423

After carefully evaluating the risks associated with all #COVID19 #vaccines available in #India, & after getting the expert opinion of specialists, I got double #vaccinated with #BharatBiotech's #Covaxin in '21. My family & 2 of my friends did the same.

Except for 1 friend, the rest of us all eventually got a mild form of #COVID in '22, which we recovered from (2 ~ 5 days). So, I was planning to avoid the booster dose.

Now, I don't mind getting the #nasalvaccine, because it is VERY SAFE! 👍 👌 👏

Bravo #BharatBiotech! 👏👏

The ONLY way to deal with #COVID #vaccine hesitancy among citizens is by making vaccines SAFER & by being very TRANSPARENT about their #sideeffects, and NOT by the outrageous #vaccinemandates!

Bharat Biotech's #Covaxin is among the safest #COVID19 #vaccines. It is a whole-virion inactivated vaccine, & has reported very few adverse events.

Now, Bharat Biotech has released AN EVEN SAFER #nasalvaccine, the non-injected nasal version of Covaxin! 👏

https://www.indiatoday.in/coronavirus-outbreak/story/bharat-biotech-nasal-covid-vaccine-out-as-booster-dose-2312377-2022-12-22

#Covaxin Was Rushed Under Political Pressure, Need for Speed: STAT Report #CoronavirusPandemic https://m.thewire.in/article/government/bharat-biotech-rushed-covaxin-political-pressure-stat

https://www.statnews.com/pharmalot/2022/11/15/vaccine-covid19-india-bharat-covaxin-transparency-protocols/

Serious lapses has been exposed in the making of #COVAXIN and the way Govt diluted mandatory protocols for PR.

This should be seen with the way many died in an African nation due to our drug.

RG raised this, they accused us of Vaccine hesitancy.

RT @Banjotkaur
WHO found Good Manufacturing Practises violations at #BharatBiotech's unit making #Covaxin in March. The firm gave corrective plan in June. But WHO rejected it. The unit is operating at unacceptable level of quality standards, it now says.A video explainer https://youtu.be/fILRIPs_eGI

Kya beizzati
---
RT @GorwayGlobal
#Covaxin's woes continue
https://science.thewire.in/health/exclusive-covaxin-manufacturing-practice-remain-unacceptable-who/
https://twitter.com/GorwayGlobal/status/1562158286484525056

RT @Banjotkaur
Though #BharatBiotech is now waiting to launch an all new intranasal vaccine against #Covid_19 pending regulator's nod, its problems with #Covaxin are still far from over ever since #WHO suspended its supply for UN agencies in April (1/n) https://science.thewire.in/health/exclusive-covaxin-manufacturing-practice-remain-unacceptable-who/

6-12 வயதினருக்கு இன்று முதல் கொரோனா தடுப்பூசி
https://patrikai.com/the-first-corona-vaccine-for-6-12-year-olds-today/ via @patrikaidotcom@twitter.com

#COVID19 #COVID #vaccination #VaccinationForKids #COVAXIN

#Breaking கோவாக்சின் தடுப்பூசியை 6-12 வயது சிறார்களுக்கு செலுத்த அனுமதி - இந்திய மருந்து கட்டுப்பாட்டு ஆணையம் ஒப்புதல்!!

#COVAXIN #Vaccine #India http://patrikai.com

தனியார் மருத்துவமனைகளில் கோவாக்சின், கோவிஷீல்டு தடுப்பூசிகளின் ஒரு டோஸ் ரூ.225 என குறைப்பு!
https://patrikai.com/covishield-covaxin-price-cut-to-rs-225-per-dose-for-private-hospitals/ via @patrikaidotcom@twitter.com

#COVAXIN #COVISHIELD #price #hospitals

So, in effect, Bharat Biotech say that they have as much legitimacy as Indian Institute of Planning and Management!

RT @svaradarajan@twitter.com

So 14 deeply reported #Covaxin stories— published over a year—ordered to be taken down by a local AP court with no notice served on @TheWire_in@twitter.com, no chance given for us to refute whatever false claims @BharatBiotech@twitter.com has made against us!

Let me say this—BB’s bullying will not work https://twitter.com/barandbench/status/1496513080314204160

RT @svaradarajan
So 14 deeply reported #Covaxin stories— published over a year—ordered to be taken down by a local AP court with no notice served on @thewire_in, no chance given for us to refute whatever false claims @BharatBiotech has made against us!

Let me say this—BB’s bullying will not work https://twitter.com/barandbench/status/1496513080314204160

Thanks you - but these are Concerns along with your Clarification Statements and not False Statements with Fact Checks...
---
RT @BharatBiotech
COVAXIN® - Fact Check- Issued in Public Interest

#Covaxin #COVID19Vaccine #COVID19 #BharatBiotech
https://twitter.com/BharatBiotech/status/1478770428562706436

---
RT @bsindia
The multi-dose vial policy saves money for procurement agencies by reducing the cold chain logistics

@sohinidastweets reports

#Covaxin #BharatBiotech #CoronavirusVaccine
https://mybs.in/2ZjoRlQ
https://twitter.com/bsindia/status/1473119783315025926

RT @RijoMJohn@twitter.com

BB enjoys a virtual monopoly over #Covaxin despite being co-developed with public resources. GoI gets a mere 5% royalty on net sales. It's sold at twice the price of Covishield. On transparency, the less said the better.

Yet, you call it a TRUE EXAMPLE of PPP? Give it a break! https://twitter.com/ICMRDELHI/status/1463130579751215107

🐦🔗: https://twitter.com/RijoMJohn/status/1463133838226329601

Mitha sa thappad #COVAXIN

RT @GorwayGlobal
@maryashakil @DrTedros Let's hope these so called sources are merely sources of #Sycophancy. If word gets out that #Covaxin approval was thanks to ModiJi's intervention with @WHO's @DrTedros then it'll never sell internationally.

உலக சுகாதார அமைப்பு கோவாக்சின் தடுப்பூசி மருந்துக்கு அங்கீகாரம் https://patrikai.com/who-approves-covaxin-vaccine/ via @patrikaidotcom@twitter.com

#COVAXIN #who @BharatBiotech@twitter.com @MoHFW_INDIA@twitter.com @WHO@twitter.com

All clinical trials still be done in CMC Vellore.

If you get it, you get it.
---
RT @MomentsIndia
The Christian Medical College (CMC) in #Vellore will conduct the study and clinical trials following the approval of the #DCGI on mixing #COVISHIELD and #Covaxin. https://twitter.com/i/events/1425371042457944072
https://twitter.com/MomentsIndia/status/1425431906418663436